Author:
Johnson Catherine,Terrell Jesse,Blieden Lauren,Wirostko Barbara
Reference12 articles.
1. Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research;X Yang;Front Neurol,2022
2. Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies;F Kong;Front Pharmacol,2023
3. Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats;Abdel-Latif Rg;Naunyn Schmiedebergs Arch Pharmacol,2018
4. Trial of Lixisenatide in Early Parkinson's Disease;W G Meissner;N Engl J Med,2024
5. Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma;Ecn Lawrence;Front Cell Neurosci,2023